Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...

Auxilium Pharmaceuticals announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA for Xiaflex (collagenase clostridium histolyticum or CCH) for the potential ...

The Food and Drug Administration (FDA) has approved Xiaflex as the first non-surgical treatment for Peyronie’s disease (PD), a condition that causes penis curvature that can make sexual intercourse ...

DC can return after any treatment, leaving patients and providers unsure about next steps. Keenova supports research that expands the evidence base and helps hand specialists understand how ...

Auxilium Pharmaceuticals announced positive top-line data from its open-label phase 3b trial evaluating Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s ...

Endo is taking its Peyronie's disease campaign from the vegetable aisle to the pool hall. Having initially relied on wonky veg to discuss the men’s health condition, the drugmaker has now brought four ...

Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the ...

Firm plans 2012 sBLA filing with FDA for collagenase Clostridium histolyticum product. Auxilium Pharmaceuticals reported positive data from its two Phase III studies evaluating Xiaflex® (collagenase ...

In the coming months you may hear about a new drug for treating cellulite, called Xiaflex. The pharmaceutical manufacturer that makes it just began clinical trials of its effects in January. I am not ...

Auxilium Pharmaceuticals says it has sold some foreign market rights for its Xiaflex hand disorder drug. Malvern, Pa.-based Auxilium (NASDAQ:AUXL) said Actelion Pharmaceuticals Ltd. bought the rights ...

NEW YORK (AP) -- Shares of Auxilium Pharmaceuticals Inc. fell Wednesday after the company said it is ending a European partnership with Pfizer Inc. for its drug Xiaflex. The news came as Auxilium ...